Patents by Inventor Peter M. Kang

Peter M. Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydrogen peroxide-activable, anti-oxidant compounds and methods using same
    Patent number: 10370391
    Abstract: The present invention includes 4-(hydroxymethyl)phenylboronic esters, which react with hydrogen peroxide to form 4-hydroxybenzyl alcohol, which is an anti-inflammatory and/or anti-oxidant compound, as well as microparticles and compositions thereof. In certain embodiments, the compositions of the invention may be used to treat or prevent oxidative stress and/or inflammation, including ischemic disease.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: August 6, 2019
    Assignees: Beth Israel Deaconess Medical Center, Inc., Chonbuk National University Industrial Cooperation Foundation
    Inventors: Peter M. Kang, Dongwon Lee, Seunggyu Park, Dahee Jeong
  • NOVEL HYDROGEN PEROXIDE-ACTIVABLE, ANTI-OXIDANT COMPOUNDS AND METHODS USING SAME
    Publication number: 20180105540
    Abstract: The present invention includes 4-(hydroxymethyl)phenylboronic esters, which react with hydrogen peroxide to form 4-hydroxybenzyl alcohol, which is an anti-inflammatory and/or anti-oxidant compound, as well as microparticles and compositions thereof. In certain embodiments, the compositions of the invention may be used to treat or prevent oxidative stress and/or inflammation, including ischemic disease.
    Type: Application
    Filed: May 1, 2017
    Publication date: April 19, 2018
    Applicants: Beth Israel Deaconess Medical Center, Inc., Chonbuk National University Industrial Cooperation Foundation
    Inventors: Peter M. Kang, Dongwon Lee, Seunggyu Park, Dahee Jeong
  • PVAX copolymer and PVAX microparticles comprising the same
    Patent number: 9844564
    Abstract: The present invention includes a vanillyl alcohol-containing copolyoxalate copolymer (PVAX). The present invention also includes a PVAX microparticle comprising PVAX. In one aspect, the compositions of the invention can be used as a drug delivery system, an antioxidant or anti-inflammatory composition, a composition for preventing or treating ischemic disease, a composition for inhibiting the side effects of anticancer drugs, a contrast agent, and/or a composition for diagnosing ischemic disease.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: December 19, 2017
    Assignees: Industrial Cooperation Foundation Chonbuk University, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Dong Won Lee, Dong Hyun Hong, Peter M. Kang
  • Vitamin D receptor agonists and uses thereof
    Patent number: 9499488
    Abstract: This invention features vitamin D receptor agonists, and their use in treating bone disorders, cardiovascular disease, hyperparathyroidism, immune disorders, proliferative disease, renal disease, and thrombosis.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: November 22, 2016
    Assignees: Beth Israel Deaconess Medical Center, Inc., The General Hospital Corporation
    Inventors: Peter M. Kang, S. Ananth Karumanchi, Santosh Khedkar, Alan Rigby, Ravi I. Thadhani
  • PVAX COPOLYMER AND PVAX MICROPARTICLES COMPRISING THE SAME
    Publication number: 20150290239
    Abstract: The present invention includes a vanillyl alcohol-containing copolyoxalate copolymer (PVAX). The present invention also includes a PVAX microparticle comprising PVAX. In one aspect, the compositions of the invention can be used as a drug delivery system, an antioxidant or anti-inflammatory composition, a composition for preventing or treating ischemic disease, a composition for inhibiting the side effects of anticancer drugs, a contrast agent, and/or a composition for diagnosing ischemic disease.
    Type: Application
    Filed: September 13, 2013
    Publication date: October 15, 2015
    Inventors: Dong Won Lee, Dong Hyun Hong, Peter M. Kang